Pancreatic cancer is a notorious disease with a poor prognosis and low survival rates, which is due to limited advances in understanding of the molecular mechanism and inadequate development of effective treatment options over the decades. In previous studies, we demonstrated that a novel soluble protein named pancreatic adenocarcinoma up-regulated factor (PAUF) acts on tumor and immune cells and plays an important role in metastasis and progression of pancreatic cancer. Here we show that PAUF promotes adhesiveness of pancreatic cancer cells to various extracellular matrix (ECM). Our results further support a positive correlation of activation and expression of focal adhesion kinase (FAK), a key player in tumor cell metastasis and survival, with PAUF expression. PAUF-mediated adhesiveness was significantly attenuated upon blockade of the FAK pathway. Moreover, PAUF appeared to enhance resistance of pancreatic cancer cells to anoikis via modulation of FAK. Our results suggest that PAUF-mediated FAK activation plays an important role in pancreatic cancer progression.
Introduction
Pancreatic cancer, the fourth leading cause of cancer-induced mortality in both men and women, has an exceedingly poor prognosis, and is a major health issue in the developed world (Maitra and Hruban, 2008 ). An estimated 200,000 people develop and die from this disease each year (Ghaneh et al., 2007; Maitra and Hruban, 2008) . The poor prognosis of pancreatic cancer is attributed to late presentation, aggressive local invasion, early metastasis, and poor response to chemotherapy (Duffy et al., 2003) . Furthermore, retrospective studies have revealed a global increase in the overall mortality rate from pancreatic cancer, reflecting increasing incidence of pancreatic tumors (Garcea et al., 2005) . The escalating incidence and poor prognosis of pancreatic cancer emphasize the need for methods to treat and methods to identify agents that can effectively target this disease.
Previously, we identified a novel secretory protein, pancreatic adenocarcinoma up-regulated factor (PAUF), which potentiates metastasis of pancreatic cancer cells via upregulation of migration and invasion (Kim et al., 2009; Lee et al., 2010; Cho et al., 2011) . Analysis of the X-ray crystal structure revealed that PAUF is a mammalian lectin containing a β-prism motif normally found in plant lectins . In cancer cells, PAUF acts in an autocrine manner to activate the ERK, JNK and AKT intracellular signaling cascades, resulting in increased expression of the genes involved in tumor progression and metastasis (Lee et al., 2010) . Expression of CXCR4, a PAUF-inducing gene, is also positively correlated with PAUF expression in pancreatic cancer tissues from patients (Lee et al., 2010) . In immune cells, PAUF interacts with the CXCR4-TLR2 complex and inhibits CXCR4-dependent TLR2-mediated NF-κB activation in a paracrine manner . These results suggest that PAUF enhances tumorigenic potential through facilitating tumor metastasis and escaping immuno-surveillance.
Metastasis of cancer cells is regarded as a complex, multistage process involving epithelialmesenchymal transition, invasion into and dissemination through the bloodstream or lymphatic system, and colonization at specific organs (Christofori, 2006; Steeg, 2006; Sahai, 2007) . However, (A, B) The effects of PAUF overexpression (A) and knockdown (B) on cell adhesion were determined with the adhesion assay using fibronectin, collagen or vitronectin-coated plates. Cells were seeded in 96-well plates coated with each ECM molecule. After 20 min incubation at 37 o C, non-adherent cells were washed with PBS and then adherent cells were counted. (C, D) Adhesion activities of PAUF-overexpression (C) or knockdown (D) cells were measured in the presence of anti-PAUF (30 μg/ml), control antibody (heat-inactivated anti-PAUF, 30 μl/ml), or PBS. Data represent mean values ± SE. *, P ＜ 0.05, **, P ＜ 0.01.
little is known about the molecular mechanisms controlling pancreatic cancer metastasis at present. Focal adhesion kinase (FAK), a non-receptor tyrosine kinase, is associated with diverse cellular functions, including adhesion, polarization, migration and survival (Frame et al., 2010) . In cancer cells, activated FAK contributes to tumor progression and metastasis by enhancing motility, adhesiveness and resistance against apoptosis. In addition, overexpression of FAK is positively associated with tumor progression and poor prognosis (Owens et al., 1995; Lark et al., 2003; Sawai et al., 2005) . FAK regulates the adhesive behavior of pancreatic cancer through activating the Ras-ERK signaling pathways (Sawai et al., 2005) . Earlier, we showed that PAUF potentiates tumorigenicity via activation of multiple signaling pathways, including ERK, AKT and JNK (Lee et al., 2010) .
Here we extend this previous work to show that PAUF has tumorigenic potential through regulation of the activity and expression of FAK. We propose that PAUF promotes the adhesiveness and survival of pancreatic cancer cells via modulation of the kinase.
Results

PAUF promotes adhesion of pancreatic cancer cells
Previously, we reported that PAUF enhances the migration and invasion of pancreatic cancer cells (Lee et al., 2010) . In this study, we investigated whether PAUF influences the adhesiveness of pancreatic cancer cells to extracellular matrix (ECM). Compared with the respective controls, the adhesive activities of PAUF-overexpressing cell lines (Panc-1_PAUF and MiaPaca-2_PAUF) were significantly enhanced ( Figure 1A ), whereas those of PAUF-downregulated cell lines (CFPAC-1_ shPAUF and BxPC-3_shPAUF) were dramatically diminished ( Figure 1B) . The ECM molecules, fibronectin, collagen I and vitronectin, used for the adhesion assay, showed similar adhesion tendencies. The secretory nature of PAUF suggests that the protein affects the adhesiveness in an autocrine manner. As shown in Figure 1C , adhesiveness enhanced by overexpression of PAUF was attenuated upon treatment with an anti-PAUF antibody. The effect of anti-PAUF on adhesiveness was relatively low in PAUF-knockdown pancreatic cancer cells than its control cells ( Figure  1D ). These results support the theory that PAUF promotes adhesiveness of pancreatic cancer cells to ECM in an autocrine manner.
PAUF facilitates FAK-Src signaling
We examined the activation and expression of focal adhesion kinase (FAK) in cancer cells with modulated PAUF expression. Phosphorylation of FAK was increased in Panc-1_PAUF and MiaPaca-2_PAUF cell lines, compared with controls, but diminished in CFPAC-1_shPAUF and BxPC-3_ shPAUF cell lines ( Figure 2A ). Furthermore, stable overexpression of PAUF resulted in elevation of FAK expression. To regulate adhesion and migra- tion, FAK phosphorylates scaffolding molecules, such as paxillin, through formation of a FAK-Src complex (Webb et al., 2004) . FAK is fully activated after recruiting Src and forming FAK-Src complex (Bolos et al., 2010) . Both phosphorylation and expression of paxillin were enhanced in PAUFoverexpressing cells. Conversely, knockdown of PAUF led to reduced levels of activated and total paxillin ( Figure 2A ). As shown in Figure 2B , activity and expression of Src were also positively correlated with PAUF expression. We next determined whether the activation of PAUF-mediated signaling is responsible for increased pancreatic cancer cell adhesion. As shown in Figure 2C , PAUF-induced adhesiveness of Panc-1 cells was significantly attenuated upon treatment with the Src inhibitors, PP2 and Herbimycin. Treatment of Panc-1_PAUF cells with anti-PAUF antibody, which resulted in reduced adhesiveness as shown in Figure 1C , reduced expression and phosphorylation levels of Src, FAK, and paxillin ( Figure 2D ), supporting the involvement of FAK-Src signaling in this process.
PAUF enhances resistance to anoikis
Several studies have implicated FAK-Src signaling in resistance to anoikis, an apoptotic event triggered by inadequate or inappropriate cell-substrate contact (Zhao and Guan, 2009; Frame et al., 2010) . Regulation of PAUF alters not only FAK-Src signaling, but also cell-substrate contact. Accordingly, we examined whether PAUF affects anoikis induced in polyHEMA cultures of pancreatic cancer cells. As shown in Figures 3A and 3B , resistance against anoikis was enhanced in PAUF-overexpressing cell lines (Panc-1_PAUF), but reduced in PAUF-downregulated cell lines (CFPAC-1_shPAUF). Activation of caspase 3, mediated by anchorage deprivation, was significantly decreased upon overexpression of PAUF ( Figure 3C ). Consistently, suppression of PAUF enhanced anoikis-derived caspase 3 activity ( Figure 3D ). These results suggest that PAUF can 
PAUF increases focal adhesions
To elucidate whether PAUF modulates the density of focal adhesion, the site of cell-matrix adhesion, we stained cells with anti-paxillin. Focal adhesions are large macromolecular assemblies that mediate mechanical force transduction, adhesion to ECM and regulatory signals (Fraley et al., 2010) . Paxillin is a docking protein containing many proteinbinding modules that recruit and localize signaling molecules to the focal adhesion site (Schaller, 2001) . FAK localizes to and regulates focal adhesion site by binding paxillin (Schaller, 2001 ). In our experiments, PAUF-overexpressing cells formed more focal adhesions ( Figure 4A ). Focal adhesion sites were observed in both peripheral and central regions in Panc-1_PAUF cells, while the majority of focal adhesion sites were localized in the periphery of Panc-1_Mock cells. The number of focal adhesions in Panc-1_PAUF, calculated using the Image J program, was increased nearly 3-fold, compared with that in the Panc-1_Mock cell line ( Figure 4B ). Consistent with this finding, PAUF-overexpressing cells contained more polymerized F-actin than control cells. The majority of actin bundles in Panc1_Mock cells were relatively short and restricted to the periphery in control cells ( Figure 4A ). These findings indicate that PAUF facilitates focal adhesion formation.
Discussion
FAK is associated with normal cell growth responses as well as survival and metastasis of tumor cells (Brunton and Frame, 2008) . The majority of human cancers, especially highly invasive metastatic neoplasms, show elevated expression and activation of FAK (van Nimwegen and van de Water, 2007; Brunton and Frame, 2008) . Earlier reports have suggested that FAK increases cell-matrix area and focal adhesion, and suppresses anoikis in the tumor microenvironment (Duxbury et al., 2004; Zhao and Guan, 2009; Bolos et al., 2010) . These properties appear to mediate tumor metastasis. Here, we provide five lines of evidence to support PAUF-induced potentiation of metastasis through expression and activation of FAK. First, expression of PAUF was positively correlated with adhesiveness of pancreatic cancer cells to several ECM molecules in vitro. Second, anoikis was reduced upon PAUF overexpression, but induced by knockdown. Third, PAUF stimulated the FAK signaling pathway at both the expression and activation levels. Fourth, both a specific antibody against PAUF and inhibitor of the FAK signaling pathway efficiently inhibited PAUF-mediated adhesiveness. Finally, the density of the focal adhesion site, represented by paxillin staining, was dramatically increased upon PAUF overexpression.
FAK is involved in multivalent aspects of tumorigenesis through transduction of intracellular signals associated with growth factor signaling and cell-ECM interactions (Sieg et al., 2000) . In our experiments, overexpression of PAUF promoted both expression and activities of FAK and Src. For activation, FAK is autophosphorylated at its tyrosine residue 397 (Y397) where provided as a docking site for Src. The recruited Src phosphorylates additional sites on FAK and leads further activation. This activated FAK-Src complex regulates various signaling pathways and different cellular responses (Bolos et al., 2010) . The MAPK pathway is one of the well-known downstream pathways of the FAK-Src complex. Phosphorylation of FAK by Src leads to recruitment of proteins containing SH2 domains, such as Grb2. Grb2 bound to FAK recruits SOS, and activates the Ras-MAPK pathway (Mitra and Schlaepfer, 2006; Bolos et al., 2010) . Interactions of FAK and the p85 subunit of PI3K mediate activation of Akt kinase, which, in turn, protects cells from apoptosis (Reiske et al., 1999; Sonoda et al., 2000; Bolos et al., 2010) . FAK additionally activates the JNK pathway, which promotes cell motility and invasiveness (Hsia et al., 2003; Liu et al., 2007) . Previous analyses by our group have demonstrated that ERK, JNK and AKT are activated by overexpression of PAUF in pancreatic cancer cells (Lee et al., 2010) . It is possible that FAK regulated by PAUF activates the ERK, JNK and AKT pathways. We are currently investigating the possibility in detail.
The activation mode of FAK can be classified into two groups. One is anchorage-dependent activation. Cell adhesion mediated by integrins facilitates anchorage-dependent cell growth through triggering tyrosine phosphorylation of key signaling molecules, including FAK. The other mode is anchorage-independent activation of FAK. When cells lose contact with the ECM, detachment-induced cell death, also known as anoikis, is triggered. However, in the case of transformed cells, abnormal FAK activation in the absence of adhesion signals contributes to anchorage-independent growth, a hallmark of cancerous cells (Zhao and Guan, 2009) . Data from the present study showed that regulation of PAUF expression affects anoikis induced by polyHEMA culture. The increase in resistance against anoikis appears to originate from PAUFmediated FAK activation.
In conclusion, PAUF promotes cell adhesiveness to ECM molecules and protect cells from apoptosis induced by loss of anchorage. PAUF appears to contribute to metastasis of pancreatic cancer cells via induction of FAK expression and activation. Previous studies by our group have disclosed that PAUF facilitates the metastasis of pancreatic cancer cells via both autocrine and paracrine manner. The protein acts in an autocrine manner to enhance motility, invasiveness and proliferation of pancreatic cancer cells through induction of specific intracellular signaling cascades. PAUF mediates the transcriptional regulation of multiple tumor-related genes through activation of intracellular signaling. Analysis of pancreatic cancer cell lines and tissues of patients revealed close correlation of PAUF expression with that of CXCR4, a well-known metastatic factor (Li et al., 2004; Zlotnik, 2008; Lee et al., 2010) . These findings indicate that secreted PAUF in pancreatic cancer cells enhances metastatic potential by upregulating CXCR4 expression in an autocrine manner. One recent study reported that CXCR4 is closely related with adhesiveness to ECM and anoikis of cancer cells (Kochetkova et al., 2009) , suggesting that another mechanism of PAUF mediates attachment to ECM and survival. Secreted PAUF also acts on stromal cells in a paracrine manner. PAUF interacts with the CXCR4-TLR2 complex on the surface of monocytes, resulting in production of pro-tumorigenic cytokines and escape from innate immune surveillance . Data from the current investigation have provided evidence that PAUF regulates interactions between pancreatic cancer cells and ECM molecules to facilitate cell adhesiveness and resistance against anoikis. Based on the collective findings, we propose that PAUF facilitates tumor growth and metastasis through regulation of not only tumor cells, but also the tumor microenvironment.
Methods
Cell lines and materials
The human pancreatic cancer cell lines Panc-1, MiaPaCa-2, CFPAC-1, and BxPC-3 were cultured in DMEM supplemented with 10% FBS, DMEM with 10% FBS and 2.5% horse serum, IMDM with 10% FBS, and RPMI with 10% FBS, respectively. All cell lines were obtained from the ATCC (Manassas, VA) and maintained in a humidified incubator at 37 o C with 5% CO2. Generation of PAUFoverexpressing (Panc-1_PAUF and MiaPaCa-2_PAUF) or -knockdown (CFPAC-1_shPAUF and BxPC-3_shPAUF) cell lines and their respective controls is described in a previous report (Lee et al., 2010) . PP2 and herbimycin were from Calbiochem (San Diego, CA). Antibodies against Src, p-Src, FAK, p-FAK, paxillin and p-paxillin were from Cell Signaling. Anti-β-Actin antibody was from Santa Cruz (Santa Cruz, CA).
Adhesion assay
Cell adhesiveness was assayed using 96-well plate coated with fibronectin, collagen type I or vitronectin. Cells were seeded at a density of 1 × 10 4 cells/well in 100 μl of serum-free medium, and then incubated at 37 o C. Unbound cells were removed by washing twice with PBS. Attached cells were fixed and stained with 0.5% crystal violet/2% EtOH/0.1 M borated buffer (pH 9.0). Cell adhesion was quantified by counting the number of stained cells under a light microscope (Olympus). All assays were performed in triplicate and the tendencies confirmed with three independent experiments.
Anoikis assay
Anoikis was evaluated using nonadhesive polyHEMA (Sigma, Saint Louis, MO) coated 6 well plate. Cells (1 × 10 5 cells/well) were seeded and incubated for 24 h (CFPAC-1) or 48 h (Panc-1) at 37 o C. Dead cells were detected using trypan blue staining.
Caspase-3 activity assay
Caspase-3 activity was determined using the specific substrates provided by the caspase assay kit, Ac-DEVD-AMC (Peptron, Korea). Fluorophore (AMC) can be released and measured after these substrates have been cleaved by the caspase-3. After anoikis induction, cells were collected and resuspended in lysis buffer provided by the kit. After incubation with the corresponding substrate at 37 o C for 30 min, fluorescence intensities were measured with the microplate fluorometer, FLUOstar OPTIMA (BMG Labtech, Germany).
Western blot analysis
Cells lysates were prepared in RIPA buffer and culture supernatants concentrated using Microcon centrifugal filters (Millipore, Billerica, MA). Samples were subjected to SDS-PAGE, and transferred to Hybond-ECL nitrocellulose membrane (Amersham, Buckinghamshire, Sweden). Membranes were probed with an appropriate primary antibody diluted in TBST containing 5% BSA, followed by incubation with a secondary horseradish peroxidase-conjugated antibody. Bound antibody was visualized by using enhanced chemiluminescence reagents (Millipore, Billerica, MA).
Evaluation of focal adhesion
For immunofluorescence staining, 1 × 10 4 cells were seeded in Micro-Slide (Ibidi, Martinsried, Germany). Next, cells were fixed, followed by staining with anti-paxillin and phalloidin. After counterstaining with DAPI, cells were analyzed using LSM510 META confocal fluorescence microscope (Zeiss, Jena, Germany). The number of focal adhesions was counted using Image J.
Statistical analysis
Data were presented as mean values ± standard errors (SE). Unless otherwise indicated, the student's t test was used for statistical analysis, with P ＜0.05 defined as significant.
